Correlation Between ZyVersa Therapeutics and Ensysce Biosciences

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both ZyVersa Therapeutics and Ensysce Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining ZyVersa Therapeutics and Ensysce Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between ZyVersa Therapeutics and Ensysce Biosciences, you can compare the effects of market volatilities on ZyVersa Therapeutics and Ensysce Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in ZyVersa Therapeutics with a short position of Ensysce Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of ZyVersa Therapeutics and Ensysce Biosciences.

Diversification Opportunities for ZyVersa Therapeutics and Ensysce Biosciences

-0.56
  Correlation Coefficient

Excellent diversification

The 3 months correlation between ZyVersa and Ensysce is -0.56. Overlapping area represents the amount of risk that can be diversified away by holding ZyVersa Therapeutics and Ensysce Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Ensysce Biosciences and ZyVersa Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on ZyVersa Therapeutics are associated (or correlated) with Ensysce Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Ensysce Biosciences has no effect on the direction of ZyVersa Therapeutics i.e., ZyVersa Therapeutics and Ensysce Biosciences go up and down completely randomly.

Pair Corralation between ZyVersa Therapeutics and Ensysce Biosciences

Given the investment horizon of 90 days ZyVersa Therapeutics is expected to under-perform the Ensysce Biosciences. But the stock apears to be less risky and, when comparing its historical volatility, ZyVersa Therapeutics is 1.79 times less risky than Ensysce Biosciences. The stock trades about -0.11 of its potential returns per unit of risk. The Ensysce Biosciences is currently generating about 0.02 of returns per unit of risk over similar time horizon. If you would invest  93.00  in Ensysce Biosciences on August 27, 2024 and sell it today you would lose (50.00) from holding Ensysce Biosciences or give up 53.76% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

ZyVersa Therapeutics  vs.  Ensysce Biosciences

 Performance 
       Timeline  
ZyVersa Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days ZyVersa Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.
Ensysce Biosciences 

Risk-Adjusted Performance

3 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Ensysce Biosciences are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of rather weak basic indicators, Ensysce Biosciences exhibited solid returns over the last few months and may actually be approaching a breakup point.

ZyVersa Therapeutics and Ensysce Biosciences Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with ZyVersa Therapeutics and Ensysce Biosciences

The main advantage of trading using opposite ZyVersa Therapeutics and Ensysce Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if ZyVersa Therapeutics position performs unexpectedly, Ensysce Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ensysce Biosciences will offset losses from the drop in Ensysce Biosciences' long position.
The idea behind ZyVersa Therapeutics and Ensysce Biosciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.

Other Complementary Tools

Share Portfolio
Track or share privately all of your investments from the convenience of any device
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios